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Abstract
Background: Current theories underline the crucial role of pro-inflammatory mediators
produced by monocytes for the pathogenesis of sepsis. Since monocytes derive from progenitor
hemopoetic cells, the kinetics of stem cells was studied in peripheral blood of patients with sepsis.
Methods: Blood was sampled from 44 patients with septic syndrome due to ventilator-associated
pneumonia on days 1, 3, 5 and 7 upon initiation of symptoms. Concentrations of tumour necrosis
factor-alpha (TNFα), interleukin (IL)-6, IL-8 and G-CSF were estimated by ELISA. CD34/CD45 cells
were determined after incubation with anti-CD45 FITC and anti-CD34 PE monocloncal antibodies
and flow cytometric analysis. Samples from eight healthy volunteers served as controls.
Results: Median of CD34/CD45 absolute count of controls was 1.0/μl. Respective values of the
total study population were 123.4, 112.4, 121.5 and 120.9/μl on days 1, 3, 5 and 7 (p < 0.0001
compared to controls). Positive correlations were found between the absolute CD34/CD45 count
and the absolute monocyte count on days 1, 5 and 7. Survival was prolonged among patients with
less than 310/μl CD34/CD45 cells on day 1 compared to those with more than 310/μl of CD34/
CD45 cells (p: 0.022). Hazard ratio for death due to sepsis was 5.47 (p: 0.039) for CD34/CD45
cells more than 310/μl. Median IL-6 on day 1 was 56.78 and 233.85 pg/ml respectively for patients
with less than 310/μl and more than 310/μl CD34/CD45 cells (p: 0.021).
Conclusion: Stem cells are increased in peripheral blood over all days of follow-up compared to
healthy volunteers. Patients with counts on day 1 less than 310/μl are accompanied by increased
survival compared to patients with more than 310/μl.
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Sepsis syndrome is one of the leading causes of death
occurring in more than 1,500,000 patients each year in
either Europe or North America with a mortality rate rang-
ing between 35 and 50% [1]. Current theory for patho-
genesis is based on the production of pro-inflammatory
mediators like tumour necrosis factor-alpha (TNFα) and
interleukins (IL)-6 and IL-8 by cells of the innate immune
system when triggered by constituents of bacterial cells of
the responsible pathogens [2]. These cells of the innate
immune system involved in pathogenesis are myeloid
cells, mainly neutrophils and monocytes, derived from
progenitor stem cells. During evolution of the septic proc-
ess, increased apoptosis of monocytes and lymphocytes is
observed [3,4], leading to hypothesis that stem cells are
activated through hemopoetic mechanisms in order to
replace them. Despite the importance of stem cells for
maturation into neutrophils and monocytes, no data are
available in the current literature about the kinetics of
stem cells in the peripheral blood of the septic host. Stem
cells are recognized by the expression of the CD34 surface
molecule on their cell membrane [5].
The present study aimed to provide information about
stem cells circulating in blood in sepsis. In an attempt to
apply a study population as homogenous as possible,
only patients with ventilator-associated pneumonia and
sepsis were enrolled in order to minimize confounding
variables occurring when patients with different underly-
ing infections offering a great variety of antigenic stimuli
for the innate immune system were encountered together.
Methods
Study design
A total of 44 patients were enrolled in a prospective study
that took place over the period May-November 2005. The
study population was different than the one described
recently [4]. Patients were hospitalized in the Department
of Critical Care of the "Evangelismos" General Hospital
and in the 2nd Department of Critical Care of the
"ATTIKON" University Hospital of Athens. The study was
approved by the Ethics Committee of both hospitals. All
enrolled patients were intubated for at least 48 hours prior
enrolment and they were aged above 18 years. Written
informed consent was provided by their relatives.
Exclusion criteria were:
• any hematologic or solid tumor malignancy;
• any administration of G-CSF or CM-CSF over the last
three months;
• neutropenia (≤500 neutrophils/mm3);
• HIV infection; and
• oral intake of corticosteroids at a dose equal to or higher
than 1 mg/kg equivalent of prednisone for a period
greater than one month.
Inclusion criteria were the concomitant presence of:
• ventilator-associated pneumonia (VAP), and
• sepsis, severe sepsis or septic shock.
Death due to sepsis was the clinical endpoint of the study.
Definitions
Diagnosis of VAP was established in any patient present-
ing with the following signs:
• core temperature >38°C or <36°C;
• new or persistent consolidation in lung X-ray;
• purulent trancheobronchial secretions (TBS);
• clinical pulmonary infection score (CPIS) more than 6
[6-9].
CPIS was determined after individual scoring for each of
the following parameters [10], as follows:
• Core temperature 36.5–38.4°C: 0 points; 38.5–38.9°C:
1 point; ≤36°C or ≥39°C: 2 points
• White blood cells 4,000–11,000/μl: 0 points; <4,000 or
>11,000/μl: 1 point; >11,000 points and more than 10%
bands: 2 points
• pO2/FiO2 ≥240 or presence of ARDS: 0 points; pO2/FiO2
<240 in the absence of ARDS: 2 points
• Diffuse shadows on lung X-ray: 1 point; localized
shadow on lung X-ray: 2 points
• Purulent TBS: 2 points
• TBS cultures yielding a pathogen ≥106 cfu/ml with neg-
ative Gram stain: 1 point; TBS cultures yielding a patho-
gen ≥106 cfu/ml with positive Gram stain: 2 points
Diagnosis of sepsis was based on the presence of at least
two of the following [11]:
• core temperature >38°C or <36°C;
• Pco2<32 mmHg;Page 2 of 7
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• white blood cells >12,000/μl or <4,000/μl or >10%
bands.
Severe sepsis was determined as the acute dysfunction of
at least one organ i.e. the acute presentation of at least one
of the following [11]:
• Acute Respiratory Distress Syndrome (ARDS), as any
value of pO2/FiO2 below 200
• Acute renal failure, as the production of less than 0.5 ml/
Kg body weight/h of urine for at least two hours provided
that the negative fluid balance of the patient was corrected
• Metabolic acidosis as any pH<7.30 or any base deficit
greater than 5 mEq/l and serum lactate at least more than
2× normal value
• Acute coagulopathy as any platelet count <100.000/μl or
INR> 1.5
Septic shock was considered as any value of systolic pres-
sure below 90 mmHg requiring the administration of ino-
tropic agents after adequate fluid resuscitation [11].
Sample collection
Upon enrolment in the study, quantitative cultures of tra-
cheobronchial secretions (TBS) were performed; TBS were
collected after insertion of a sterile catheter in the intuba-
tion tube or in the tracheotomy connected to a negative
pressure device. Enrolled patients were followed-up on a
daily basis for a total of 28 days; evaluation comprised
lung X-rays, estimation of the pO2/FiO2 ratio and of the
APACHE II and SOFA scores.
For the estimation of cytokines and of the percentage of
CD34/CD45 cells, 5 ml of blood were sampled after ven-
ipuncture of a peripheral vein under sterile conditions on
the first, third, fifth and seventh days. Blood was collected
into sterile tubes for the estimation of cytokines and into
EDTA-coated tubes (Vacutainer, Becton Dickinson, Cock-
eysville MD) for the determination of CD34/CD45 cells.




Quantitative TBS cultures were performed immediately
after collection; 0.5 ml of sample were added into a sterile
tube with 0.5 ml of 1 mg/ml of dithiothreitol (Oxoid Ltd,
London, UK) and diluted five consecutive times 1:10. Vol-
umes of 0.1 ml of each dilution were plated onto McCo-
nkey and blood agar (Becton Dickinson, Cockeysville,
Md). Dishes were incubated for five days at 35°C and
their count was estimated after multiplying with the
appropriate dilution factor. Cultures yielding a pathogen
at a count ≥1 × 106 cfu/ml were considered positive [10].
Identification of pathogens was performed by the API20E
and the API20NE systems (bioMérieux, Paris L'Etoile,
France).
Serum cytokine measurements
Concentrations of tumour necrosis factor-alpha (TNFα),
interleukin-6 (IL-6), and IL-8 in sera were estimated in
duplicate by an enzyme immunoabsorbent assay (Dia-
clone, Paris, France). Lowest limits of detection were 0.5
pg/ml for TNFα, 6.25 pg/ml for IL-6 and 62.5 pg/ml for
IL-8. Concentrations of G-CSF (Granulocyte Colony Stim-
ulating Factor) were estimated in sera of days 1 and 3 by
an enzyme immunoabsorbent assay (R&D Systems, Min-
neapolis, USA). Lowest limit of detection was 1.25 pg/ml.
Flow cytometric analysis of hemopoetic cells
For the estimation of the percentage of CD34/CD45 cells,
whole blood was applied. Red blood cells were lysed by
the application of NH4Cl 0.1 M and white blood cells
were washed three times with PBS pH: 7.2. Subsequently,
they were incubated for 15 minutes in the dark with the
monoclonal antibodies anti-CD45 FITC (Immuotech,
Marseille, France) and anti-CD34 PE (Immunotech).
Cells staining positive for both CD34 and CD45 after
analysis by the EPICS XL/MSL flow cytometer (Beckman
Coulter Co) with gating for the whole cell population,
were considered hemopoetic stem cells [2]. IgG FITC and
IgG PE antibodies were applied as negative controls for
each sample. Mean fluorescence intensity (MFI) was also
recorded. In order to evaluate the percentage of CD34/
CD45 cells of the enrolled patient population, eight sam-
ples derived from healthy volunteers well matched for age
and sex to the study population were applied. The abso-
lute count of CD34/CD45 cells was estimated after multi-
plication of their percentage to the absolute white blood
cell count determined after analysis by an automatic
counter (Beckman Coulter Co).
Statistical analysis
Results were expressed as medians ± standard errors (SE)
or 95% confidence intervals (CI). Comparisons between
patients and healthy controls were performed by the
Mann-Whitney U test. Statistical correlations were per-
formed after assessment of the non-parametric co-effi-
cient of Spearman (rs). Survival Kaplan-Meier analysis was
performed separately for patients with CD34/CD45 cells
less than 310/μl and equal to or more than 310/μl. The
latter threshold was applied after scatterploting of single
values of survivors and non-survivors. Survival curves
were compared by the log-rank test. Cox regression analy-
sis for estimation of hazard risk (HR) and their 95%CI forPage 3 of 7
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day 1 more than 20, category of critical illness and the
count of CD34/CD45 cells on day 1 were covariates.
Changes of CD34/CD45 counts were estimated between
days 1 and 3, between days 1 and 5 and between days 1
and 7. These changes were compared for patients with
CD34/CD45 cells less than 310/μl and equal to or more
than 310/μl on day 1 by the Mann-Whitney U test. Any
value of p below 0.05 was considered statistically signifi-
cant.
Results
Clinical characteristics of patients enrolled in the study are
shown in Table 1. Median ± SE of CD34/CD45 cells of
controls was 1.0 ± 3.2/μl. Respective values of the total
study population were 123.4 ± 61.6, 112.4 ± 96.8, 121.5
± 96.8 and 120.9 ± 30.6/μl on days 1, 3, 5 and 7 of follow-
up respectively (p of comparisons of all days to controls
less than 0.0001). In these days median ± SE of MFI were
6.05 ± 0.33, 6.55 ± 0.33, 6.10 ± 0.58 and 6.15 ± 0.55
respectively. Follow-up values of CD34/CD45 cells sepa-
rately for patients with sepsis, severe sepsis and septic
shock are shown in Figure 1.
Median ± SE of neutrophils of the whole study population
on days 1, 3, 5 and 7 were 8,303.8 ± 1,064.8, 8,683.4 ±
1,051.4, 8,748.4 ± 1,086.6 and 7.659.4 ± 919.9/μl respec-
tively. No correlation was found between the absolute
CD34/CD45 count and the absolute neutrophil count of
patients in any day of follow-up. Median ± SE of mono-
cytes of the whole study population on days 1, 3, 5 and 7
were 630.3 ± 64.0, 585.5 ± 76.9, 632.9 ± 112.7 and 568.2
± 99.4/μl respectively. Positive correlations were found
between the absolute CD34/CD45 count and the absolute
monocyte count on day 1 (rs: +0.342, p: 0.031), on day 5
(rs: +0.402, p: 0.015) and on day 7 (rs: +0.359, p: 0.034).
Death from all causes supervened in 12 patients
(27.27%); death attributed to the initial septic episode
that lead to study enrolment occurred in eight patients
(18.18%). Survival curves for patients with absolute count
of CD34/CD45 cells on the first day less than 310/μl and
equal to or more than 310/μl are shown in Figure 2. Sur-
vival was prolonged among patients with less than 310/μl
(p: 0.022). Representative flow plots of the expression of
CD34 on two patients, one with less than 310/μl CD34/
CD45 cells on day 1 and another with more than 310/μl
CD34/CD45 cells on day 1, are given in Figure 3.
Median ± SE changes of CD34/CD45 counts between days
1 and 3 were -2.7 ± 25.8 and +260.4 ± 284.8/μl for
patients with CD34/CD45 cells less than 310/μl and
equal to or more than 310/μl on day 1 respectively (p:
Absolute blood counts of CD34/CD45 cells over daily fol-low-up of patients wi h ventilator-associated pneumonia (VAP) and sepsis, severe sepsis or septi  shockFigure 1
Absolute blood counts of CD34/CD45 cells over daily fol-
low-up of patients with ventilator-associated pneumonia 
(VAP) and sepsis, severe sepsis or septic shock. Circles 
denote outliers and asterisks denote extremes. ap < 0.05 
compared to sepsis.
Table 1: Demographic characteristics of 44 patients with 
ventilator-associated pneumonia (VAP) and sepsis enrolled in 
the study.
Age (years, mean ± SD) 59.56 ± 18.28
Male/Female 32/12
APACHE II score (mean ± SD) 16.49 ± 5.52
SOFA score (mean ± SD) 8.14 ± 3.39
White blood cells (mean ± SD, /μl) 12,939.8 ± 6,502.5
Sepsis [No of patients (%)] 10 (22.72)
Severe Sepsis [No of patients (%)] 12 (27.27)
Septic shock [No of patients (%)] 22 (50.00)
Underlying conditions [No (%)]
Multiple injuries 10 (22.72)
Chronic obstructive pulmonary disease 22 (50.00)
Celiac aortic aneurysm replacement 5 (11.36)
Others 5 (11.36)
Predisposing factors [No (%)]
Diabetes mellitus 2 7 (15.91)
Coronary Heart Disease 10 (22.72)
Others 5 (11.36)
Positive cultures of TBS* [No (%)] 25 (56.82)
Acinetobacter baumannii 15 (34.09)
Pseudomonas aeruginosa 7 (15.91)
Others 3 (6.82)
*Tracheobronchial secretionsPage 4 of 7
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5 were -41.9 ± 111.4 and 231.4 ± 256.9/μl (pNS) and
between day 1 and 7 12.2 ± 19.23 and 366.1 ± 311.2/μl
(p: 0.004).
HR for death due to sepsis was 4.49 (pNS, 95%CI:
0.9122.108) for APACHE II more than 20, 2.19 (pNS,
95%CI: 0.50–9.57) for category of critical illness and 5.47
(p: 0.027, 95%C: 1.21–24.65) for CD34/CD45 cells
≥310/μl.
Median ± SE TNFα of the whole study population on days
1, 3, 5 and 7 were 9.12 ± 2.17, 10.02 ± 3.30, 9.724 ± 35.41
and 8.61 ± 18.92 pg/ml respectively. Median ± SE IL-6 of
the whole study population on days 1, 3, 5 and 7 were
67.86 ± 19.89, 66.62 ± 14.89, 57.14 ± 14.79 and 59.15 ±
13.41 pg/ml respectively. Median ± SE IL-8 of the whole
study population on days 1, 3, 5 and 7 were 112.5 ±
156.8, 62.5 ± 282.1, 275.6 ± 165.0 and 125.0 ± 96.1 pg/
ml respectively. Median ± SE G-CSF of the whole study
population on days 1 and 3 were 78.13 ± 53.75 and 73.21
± 60.56 pg/ml respectively. Lack of any correlation was
noted between CD34/CD45 absolute counts and serum
levels of TNFα, IL-6, IL-8 and G-CSF on each day of fol-
low-up.
Median ± SE TNFα on day 1 were 9.54 ± 2.45 and 21.33 ±
6.55 pg/ml respectively for patients with less than 310/μl
Flow plots of the expression of CD34 in two patients with ventilator-associated pneumonia (VAP) and sepsis on day 1; patient A with 180/μl CD34/CD45 cells and patient B w th 1,737/μl CD34/CD45 cellsigure 3
Flow plots of the expression of CD34 in two patients with ventilator-associated pneumonia (VAP) and sepsis on day 1; patient 
A with 180/μl CD34/CD45 cells and patient B with 1,737/μl CD34/CD45 cells.
Survival curves of 44 patients with ventilator-associated pneumonia (VAP) and sepsis in relatio  to the absolu  blood count f CD34/CD 5 cells o the f rst d y of diagnosisFig re 2
Survival curves of 44 patients with ventilator-associated 
pneumonia (VAP) and sepsis in relation to the absolute blood 
count of CD34/CD45 cells on the first day of diagnosis.Page 5 of 7
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(pNS). Respective values for IL-6 were 56.78 ± 22.16 and
233.85 ± 67.87 pg/ml (p: 0.021); for IL-8 were 71.3 ± 111.
9 and 62.5 ± 105.2 pg/ml (pNS); and for G-CSF were
78.12 ± 64.41 and 78.12 ± 71.99 pg/ml (pNS).
Discussion
Current theories for the pathogenesis of sepsis implicate
the dominant role of cells of the innate immune system
i.e. monocytes and neutrophils for the biosynthesis of
pro-inflammatory mediators after triggering by bacterial
pathogens [2]; these mediators elicit further clinical signs
of the septic host. Neutrophils and monocytes constitute
myeloid cells derived from progenitor hemopoetic stem
cells that are CD34/CD45-positive cells [5]. Based on the
hypothesis that white blood cells die through apoptosis in
sepsis [3,4], stem cells may be triggered for further expan-
sion. Since no data are available in the current literature,
the present study was assigned to the kinetics of progeni-
tor stem cells in the peripheral circulation of septic
patients.
Results revealed that the percentage of stem cells in blood
of septic patients was higher than in healthy volunteers, a
phenomenon observed for all the first seven days of fol-
low-up. The latter finding was particularly pronounced in
the event of severe sepsis (Figure 1).
The most important finding of the present study was the
existence of a correlation between CD34/CD45 count of
day 1 and the patients' outcome. Time of survival was
decreased for patients with stem cells equal to or more
than 310/μl in their blood compared to patients with
stem cells less than 310/μl (Figure 2). That finding was
further verified by Cox regression analysis revealing that
presence of ≥310/μl stem cells was accompanied by a sig-
nificantly increased risk of death of 5.47 times more than
in patients with less than 310/μl stem cells. No data are
available in the literature that may explain the described
correlation between the level of stem cells in blood and
time of survival. As a consequence, only hypotheses can
be made. Based on the detected positive correlation
between CD34/CD45 counts and monocytes counts, it
might be presumed that increased progenitor cells would
give rise to increased hemopoesis of monocytes and to
subsequent augmented burden of pro-inflammatory
mediators. It was of striking importance to show that in
patients with CD34/CD45 higher than 310/μl on day 1,
their counts fell on the consecutive days underlying the
importance of increased hemopoesis of day 1 for the out-
come of the patient.
The search for the impact of circulating pro-inflammatory
cytokines on the count of stem cells, showed that circulat-
ing levels of IL-6 were higher on day 1 among patients
with CD34/CD45 higher than 310/μl compared to
patients with less than 310/μl. A similar difference was
not detected for TNFα, IL-8 or G-CSF. The importance of
IL-6 for triggering of hemopoesis on day 1 might be sup-
ported from in vitro evidence describing IL-6 as a pro-
moter of the expansion of progenitor hemopoetic cells
[13,14].
The above results are strengthened in the light of a study
population being as homogenous as possible. All enrolled
patients became septic by the same underlying infection
i.e. VAP. That study design allowed to elaborate a similar
antigenic stimulus to the immune system of all patients
concerning the infective focus. Analysis revealed that
patients were predominantly infected by species of Pseu-
domonas aeruginosa and by Acinetobacter baumannii (Table
1) so that the offered bacterial triggering to the entire pop-
ulation was the most homogenous possible.
Conclusion
This is the first study in the literature, describing the kinet-
ics of stem cells in the septic process. They are increased
over all days of follow-up compared to healthy volunteers
and they are positively correlated to absolute monocyte
counts. Moreover their count on day 1 is correlated to
time of survival since patients with less than 310/μl sur-
vived longer compared to patients with equal to or more
than 310/μl. The latter data might unravel a novel patho-
physiological pathway that although that may not be
applied directly in clinical practice, their importance is
enormous since all novel therapies for the septic host are
targeting the pathogenetic cascade.
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